This functionality is implemented using Javascript. It cannot work without it, etc...

Estamos cargando la información...

Saltar al contenido

Hematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors

Single autologous hematopoietic cell transplantation (HCT) may be considered medically necessary as salvage therapy for germ cell tumors:
in patients with favorable prognostic factors that have failed a previous course of conventional-dose salvage chemotherapy; or

in patients with unfavorable prognostic factors as initial treatment of first relapse (ie, without a course of conventional-dose salvage chemotherapy) and in patients with platinum-refractory disease. (See Policy Guidelines section for prognostic factors.)

Tandem autologous HCT or transplant with sequential high-dose chemotherapy may be considered medically necessary for the treatment of testicular tumors either as salvage therapy or with platinum-refractory disease.

Autologous HCT is considered investigational as a component of first-line treatment for germ cell tumors.

Allogeneic HCT is considered investigational to treat germ cell tumors, including, but not limited, to its use as therapy after a prior failed autologous HCT.

787-277-6653 787-474-6326